Ovarian cancer

You have access
Effects of Curcumin and Its Analogue Desmethoxycurcumin on miR-133b and Its Target Gene GSTP-1 in Cisplatin-resistant Ovarian Cancer Cells
ESİN BAYRALI ÜLKER, ESİN ÇETİN AKTAŞ, MEHMET FATİH SEYHAN, TURGAY İSBİR, DERYANAZ BİLLUR and ÖZLEM TİMİRCİ-KAHRAMAN

Anticancer Research December 2024, 44 (12) 5351-5359; DOI: https://doi.org/10.21873/anticanres.17362
You have access
Fostamatinib Inhibits the Proliferation of Ovarian Cancer Cells Through Apoptosis Induction
HYE MIN LEE, HEE JIN CHO, YUL MIN LEE, HYUN JUNG KIM and KYUN HEO

Anticancer Research November 2024, 44 (11) 4895-4903; DOI: https://doi.org/10.21873/anticanres.17315
You have access
Repurposing Valrubicin as a Potent Inhibitor of Ovarian Cancer Cell Growth
JAEEUN LEE and KYUN HEO

Anticancer Research October 2024, 44 (10) 4301-4307; DOI: https://doi.org/10.21873/anticanres.17259
Open Access
Mast Cell-related Prognosis Signature Characterizes Immune Landscape and Predicts Prognosis of Ovarian Cancer
QINGHUA LI, TIANYUN GUAN, JIANXIONG MAO, BENJAMIN P. KING, KESIYA JOHNSON, TRENTON G. MAYBERRY, BRAYDON C. COWAN, MARK R. WAKEFIELD, YUJIANG FANG and QINGYU ZHAO

Anticancer Research July 2024, 44 (7) 2775-2786; DOI: https://doi.org/10.21873/anticanres.17089
Open Access
Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro Model
ALESSANDRO MOREA, SAYEH SARAVI, CRISTINA SISU, MARCIA HALL, SABRINA TOSI, EMMANOUIL KARTERIS and CLELIA TIZIANA STORLAZZI

Anticancer Research May 2024, 44 (5) 1817-1827; DOI: https://doi.org/10.21873/anticanres.16983
Open Access
Therapeutic Options Targeting the Ataxia-Telangiectasia Mutated (ATM)-mediated DNA Damage Response, Macropinocytosis, and Adaptive Immunity in Ovarian Cancer
CAI-CHIEH TSENG, MIN-HSI KU, YUN-CHIEH WU, WEI-LUN HUANG, WEI-MING WU, CHING HUA PAI and CHI-WEI CHEN

Anticancer Research April 2024, 44 (4) 1353-1364; DOI: https://doi.org/10.21873/anticanres.16931
You have access
Post-traumatic Stress and Depressive Symptoms in Women With Ovarian Cancer 3-6 Months After Diagnosis
CLAUDIA CARMASSI, VIRGINIA PEDRINELLI, SARA FANTASIA, DEBORA ANDREOLI, FEDERICO GIOVANNONI, ENRICO MASSIMETTI, STEFANIA COSIO, LILIANA DELL’OSSO and ANGIOLO GADDUCCI

Anticancer Research February 2024, 44 (2) 829-838; DOI: https://doi.org/10.21873/anticanres.16875
Open Access
Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer
LISA ISODA, EMIKO SONODA-FUKUDA, HIROAKI FUJINO, TORU TAKARADA, KOSEI HASEGAWA, NORIYUKI KASAHARA and SHUJI KUBO

Anticancer Research December 2023, 43 (12) 5311-5317; DOI: https://doi.org/10.21873/anticanres.16734
You have access
Elucidating the Cancer Phenotype in Turner Syndrome: A 20-Year Observational Cohort Study
YU-NAN HUANG, SHAO-CHIA CHEN, JO-CHING CHEN, KAI-WEN LIU, SHANG-LUN CHIANG, DA-TIAN BAU, PEN-HUA SU and CHUNG-HSING WANG

Anticancer Research November 2023, 43 (11) 5073-5081; DOI: https://doi.org/10.21873/anticanres.16707
Open Access
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI

Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647

Main menu

User menu

Search

Ovarian cancer

Pages